Business Description
Clinomics Inc
ISIN : KR7352770002
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.97 | |||||
Debt-to-EBITDA | -1.54 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.28 | |||||
Beneish M-Score | -5.94 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.3 | |||||
3-Year EBITDA Growth Rate | -32.7 | |||||
3-Year EPS without NRI Growth Rate | -27.6 | |||||
3-Year FCF Growth Rate | 11.7 | |||||
3-Year Book Growth Rate | -10.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.86 | |||||
9-Day RSI | 45.05 | |||||
14-Day RSI | 44.13 | |||||
6-1 Month Momentum % | -70.89 | |||||
12-1 Month Momentum % | -75.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.32 | |||||
Quick Ratio | 0.32 | |||||
Days Inventory | 120.15 | |||||
Days Sales Outstanding | 70.82 | |||||
Days Payable | 30.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | 20.78 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 3.11 | |||||
Operating Margin % | -283.58 | |||||
Net Margin % | -416.19 | |||||
FCF Margin % | -281.99 | |||||
ROE % | -77.79 | |||||
ROA % | -37.2 | |||||
ROIC % | -22.72 | |||||
ROC (Joel Greenblatt) % | -76.7 | |||||
ROCE % | -48.91 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.76 | |||||
PB Ratio | 0.45 | |||||
Price-to-Tangible-Book | 0.58 | |||||
EV-to-EBIT | -1.93 | |||||
EV-to-EBITDA | -2.17 | |||||
EV-to-Revenue | 6.17 | |||||
EV-to-FCF | -2.1 | |||||
Earnings Yield (Greenblatt) % | -51.9 | |||||
FCF Yield % | -135.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clinomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 8,246.067 | ||
EPS (TTM) (â‚©) | -1092.262 | ||
Beta | 1.22 | ||
Volatility % | 59.65 | ||
14-Day RSI | 44.13 | ||
14-Day ATR (â‚©) | 69.776914 | ||
20-Day SMA (â‚©) | 588.15 | ||
12-1 Month Momentum % | -75.26 | ||
52-Week Range (â‚©) | 449 - 3080 | ||
Shares Outstanding (Mil) | 38.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clinomics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clinomics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Clinomics Inc Frequently Asked Questions
What is Clinomics Inc(XKRX:352770)'s stock price today?
When is next earnings date of Clinomics Inc(XKRX:352770)?
Does Clinomics Inc(XKRX:352770) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |